Literature DB >> 8791520

Fibrillln mutations in Marfan syndrome and related phenotypes.

F Ramirez1.   

Abstract

A casual association has been established between mutations in the fibrillin 1 gene and Marfan syndrome and related phenotypes. Analysis of mutations in these disease types has provided new insights into microfibril assembly and function. These include evidence for a mutation in a fibrillin 1 domain associated with severe phenotype; indication of profibrillin processing by a furin-like endoprotease; linkage between extracellular processing and fibrillin 1 polymerization; and involvement of calcium binding in monomer stabilization and microfibril assembly. Identification of intragenic DNA polymorphisms and determination of intron/exon junction sequences have significantly improved our ability to diagnose Marfan syndrome and to detect fibrillin 1 mutations. Additional work has provided strong evidence for structural and functional heterogeneity of microfibrillin. The evidence includes the identification of fibrillin 2, a microfibrillar component structurally related to fibrillin 1; the differential pattern of gene expression of the two fibrillin; and the association of fibrillin 2 mutations with congenital contractural arachnodactyly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8791520     DOI: 10.1016/s0959-437x(96)80007-4

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  19 in total

1.  Elastic-fiber pathologies: primary defects in assembly-and secondary disorders in transport and delivery.

Authors:  Z Urbán; C D Boyd
Journal:  Am J Hum Genet       Date:  2000-06-06       Impact factor: 11.025

2.  Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling.

Authors:  J L Ashworth; G Murphy; M J Rock; M J Sherratt; S D Shapiro; C A Shuttleworth; C M Kielty
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 3.  A bit of give and take: the relationship between the extracellular matrix and the developing chondrocyte.

Authors:  Danielle J Behonick; Zena Werb
Journal:  Mech Dev       Date:  2003-11       Impact factor: 1.882

Review 4.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 5.  Cultured epithelial autografts: diving from surgery into matrix biology.

Authors:  M Raghunath; M Meuli
Journal:  Pediatr Surg Int       Date:  1997-09       Impact factor: 1.827

6.  A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly.

Authors:  C Maslen; D Babcock; M Raghunath; B Steinmann
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

7.  Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1.

Authors:  L Pereira; S Y Lee; B Gayraud; K Andrikopoulos; S D Shapiro; T Bunton; N J Biery; H C Dietz; L Y Sakai; F Ramirez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

8.  Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice.

Authors:  G Kostka; R Giltay; W Bloch; K Addicks; R Timpl; R Fässler; M L Chu
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

9.  Paucity of skeletal manifestations in Hispanic families with FBN1 mutations.

Authors:  Carlos Villamizar; Ellen S Regalado; Van Tran Fadulu; Sumera N Hasham; Prateek Gupta; Marcia C Willing; Shao-Qing Kuang; Dongchuan Guo; Ann Muilenburg; Richard W Yee; Yuxin Fan; Jeffrey Towbin; Joseph S Coselli; Scott A LeMaire; Dianna M Milewicz
Journal:  Eur J Med Genet       Date:  2009-11-23       Impact factor: 2.708

Review 10.  Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis.

Authors:  Jeffrey A Jones; Francis G Spinale; John S Ikonomidis
Journal:  J Vasc Res       Date:  2008-09-02       Impact factor: 1.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.